Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/15/2847299/0/en/Rani-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/05/2823504/0/en/Rani-Therapeutics-Announces-Positive-Topline-Results-from-Phase-1-Study-of-an-Oral-Anti-Interleukin-12-23-Antibody-RT-111.html
https://www.globenewswire.com//news-release/2023/12/14/2796207/0/en/Rani-Therapeutics-Announces-Preclinical-Pharmacodynamic-Data-on-Transenteric-Delivery-of-GLP-1-Incretin-Triagonist.html
https://www.globenewswire.com//news-release/2023/11/08/2776683/0/en/Rani-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-Provides-Corporate-Update.html
https://www.fiercebiotech.com/biotech/rani-and-sangamo-jettison-staff-offices-and-assets-keep-businesses-afloat-next-year
https://www.globenewswire.com//news-release/2023/11/01/2771720/0/en/Rani-Therapeutics-Announces-Strategic-Program-Prioritization-Expansion-of-Manufacturing-and-Plans-to-Streamline-Business-Operations-to-Support-Near-Term-Value-Drivers-and-Long-Term.html
https://www.globenewswire.com//news-release/2023/10/25/2766457/0/en/The-RaniPill-Capsule-Rani-Therapeutics-Oral-Delivery-Platform-was-Well-Tolerated-in-60-Day-Repeat-Administration-GLP-Safety-Study.html
https://www.globenewswire.com//news-release/2023/10/19/2763668/0/en/Rani-Therapeutics-Announces-Successful-Oral-Delivery-of-Monoclonal-Antibody-via-High-Capacity-Pill-in-Preclinical-Study.html
https://www.globenewswire.com//news-release/2023/10/12/2759645/0/en/Rani-Therapeutics-to-Present-Abstract-on-RT-102-at-the-2023-Annual-Meeting-of-the-American-Society-for-Bone-and-Mineral-Research.html
https://www.globenewswire.com//news-release/2023/09/18/2744697/0/en/Rani-Therapeutics-Initiates-Phase-1-Study-of-RT-111-RaniPill-Containing-Ustekinumab-Biosimilar-CT-P43.html